Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$1.21 – $5.05
81% from low
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $39.2M | $44.9M | $41.7M | $44.1M | $55.1M | $60.4M | $64.1M | $70.7M |
| Cost of revenue | $22.3M | $23.9M | $23.3M | $25.6M | $30.9M | $36.0M | $37.6M | $40.7M |
| Gross profit | $16.9M | $21.0M | $18.4M | $18.4M | $24.2M | $24.4M | $26.6M | $30.1M |
| Gross margin | 43.2% | 46.8% | 44.1% | 41.8% | 43.9% | 40.4% | 41.4% | 42.5% |
| R&D | $4.1M | $3.7M | $4.5M | $4.8M | $4.9M | $7.0M | $7.7M | $8.6M |
| Operating income | −$1.3M | $2.2M | $269.0K | −$1.6M | −$4.3M | −$19.8M | −$20.5M | −$25.2M |
| EBITDA | $295.0K | $4.2M | $2.4M | $309.0K | −$319.5K | −$18.4M | −$15.9M | −$25.0M |
| Net income | −$338.0K | $1.5M | −$1.7M | $700.0K | −$2.9M | −$21.2M | −$19.0M | −$29.3M |
| Net margin | -0.9% | 3.4% | -4.1% | 1.6% | -5.3% | -35.0% | -29.7% | -41.5% |
| EPS (diluted) | -0.01 | 0.05 | -0.06 | 0.02 | -0.09 | -0.57 | -0.51 | -0.78 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $59M | $-0.77 | $-0.81–$-0.74 | 2 |
| 2027 | $64M | $-0.60 | $-0.65–$-0.55 | 2 |
| 2028 | $73M | $-0.46 | $-0.67–$-0.27 | 3 |
| 2029 | $108M | $-0.09 | $-0.09–$-0.08 | 1 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds EDAP.
No tracked institution reports a position in EDAP as of their last filing.
No one on the platform has traded EDAP yet.
| $59M |
| — |
| LUNGPulmonx Corporation | $1.33 | +6.40% | $56M | — |
| MDAISpectral AI, Inc. | $1.69 | -1.17% | $54M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 2.6× sales vs its 4.4× historical median P/S.
Fair value ≈ $7.39 · price $4.32 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.